Cross Country Healthcare Q2 EPS $0.69 Beats $0.61 Estimate, Sales $540.70M Beat $531.68M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cross Country Healthcare (NASDAQ:CCRN) reported Q2 earnings of $0.69 per share, beating the analyst consensus estimate of $0.61 by 13.11%. However, this is a 50.71% decrease from the same period last year. The company also reported quarterly sales of $540.70 million, beating the analyst consensus estimate of $531.68 million by 1.70%, but this is a 28.25% decrease from the same period last year.
August 04, 2023 | 12:17 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Cross Country Healthcare's Q2 earnings and sales beat estimates but are significantly down from the same period last year. This mixed result could lead to uncertainty in the market.
While Cross Country Healthcare beat analyst estimates for Q2, the significant decrease in earnings and sales compared to the same period last year could lead to uncertainty among investors. This could potentially impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100